Kronos Advanced Technologies Inc. owns all common shares and maintains full voting control of KronosMD Inc. Additionally, KronosMD’s preferred shareholders collectively hold over 5,000,000 shares with ...
Global Pharmaceutical Sterility Testing Market Set For Explosive Growth, Projected To Reach USD 3,815.6 Million By 2033 Regional Analysis of Pharmaceutical Sterility Testing Market North America holds ...